TABLE 1.
Available datasets from Study MS200527_0019 and Study MS200527_0017
| ID | Study MS200527_0019 | Study MS200527_0017 | Total | |||
|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |
| 18 | 24 | 58 | 76 | 76 | 100 | |
| Observations | ||||||
| All | 576 | 100 | 1750 | 100 | 2326 | 100 |
| 25 mg q.d. | – | – | 434 | 25 | 434 | 19 |
| 75 mg q.d. | 576 | 100 | 882 | 50 | 1458 | 63 |
| 200 mg q.d. | – | – | 434 | 25 | 434 | 19 |
| BLQ observations | ||||||
| All | 166 | 29 | 509 | 29 | 675 | 29 |
| 25 mg q.d. | – | – | 195 | 11 | 195 | 8 |
| 75 mg q.d. | 166 | 29 | 265 | 15 | 431 | 19 |
| 200 mg q.d. | – | – | 49 | 3 | 49 | 2 |
| Predose | 36 | 6 | 74 | 4 | 110 | 5 |
| Postdose | 130 | 23 | 435 | 25 | 565 | 24 |
| Fed/fasted observations | ||||||
| Fed | 288 | 50 | 224 | 13 | 512 | 22 |
| Fasted | 288 | 50 | 1526 | 87 | 1814 | 78 |
Abbreviations: BLQ, below the limit of quantification; N, number of participants/observations; q.d., once‐daily.